Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v14-EN | Version v7-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2021-04-02 | 2021-03-01 |
| Drug Identification Number | 00431648 | 00431648 |
| Brand name | PNEUMOVAX 23 | PNEUMOVAX 23 |
| Common or Proper name | (pneumococcal vaccine, polyvalent) | (pneumococcal vaccine, polyvalent) |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F | PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20 PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F |
| Strength(s) | 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG | 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS | INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS |
| Packaging size | 1x dose vial | 1x dose vial |
| ATC code | J07AL | J07AL |
| ATC description | BACTERIAL VACCINES | BACTERIAL VACCINES |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2020-12-01 | 2020-12-01 |
| Actual start date | 2020-10-06 | 2020-10-06 |
| Estimated end date | 2021-04-01 | 2021-03-31 |
| Actual end date | 2021-04-01 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination. | Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination. |
| Health Canada comments |